Pages that link to "Q73382343"
Jump to navigation
Jump to search
The following pages link to Atypical facial pain: a double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan (Q73382343):
Displaying 10 items.
- Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory pain (Q34555809) (← links)
- Neurovascular relationship at the trigeminal root entry zone in persistent idiopathic facial pain: findings from MRI 3D visualisation (Q35484598) (← links)
- Where do triptans act in the treatment of migraine? (Q35748273) (← links)
- Sumatriptan inhibits TRPV1 channels in trigeminal neurons (Q35928518) (← links)
- Serotonin type 1D receptors (5HTR) are differentially distributed in nerve fibres innervating craniofacial tissues. (Q37192862) (← links)
- Pathophysiology of Migraine: A Disorder of Sensory Processing (Q39127073) (← links)
- The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons. (Q43919478) (← links)
- 5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study (Q73964511) (← links)
- Chapter 39 Atypical facial pain and burning mouth syndrome (Q82028923) (← links)
- Headache or facial pain attributed to disorders of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial or cranial structures (Q84979078) (← links)